Design Therapeutics (DSGN) Share-based Compensation (2020 - 2026)
Design Therapeutics (DSGN) posted Share-based Compensation of $3.87 million for Q2 2026, down 3.0% from $3.99 million a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
Design Therapeutics (DSGN) Share-based Compensation (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Design Therapeutics was $14.82 million, up 5.0% year-over-year; for FY2025, it was $14.55 million, up 11.3% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 100.4% (FY2020 to FY2025).
- In prior years, Design Therapeutics' Share-based Compensation was $13.07 million in FY2024 (-0.1%), $13.09 million in FY2023 (+19.8%), $10.93 million in FY2022 (+133.0%) and $4.69 million in FY2021 (+942.0%).
- Quarterly Share-based Compensation has run from a low of $1.24 million in Q3 2021 to a high of $3.99 million in Q2 2025 over five years.
- On a year-over-year basis, Share-based Compensation increased in five of the last eight quarters, with growth averaging 9.8%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 269.6%; the weakest was Q4 2023, with a decline of 11.4%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $3.92 million (Q1 2026), $3.44 million (Q4 2025) and $3.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Design Therapeutics | 693.18 Mn | -162.85 Mn | - | 3.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.87 Mn |
| Mar 31, 2026 | 3.92 Mn |
| Dec 31, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.99 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.18 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 3.72 Mn |
| Mar 31, 2023 | 3.43 Mn |
| Dec 31, 2022 | 3.08 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | 1.24 Mn |
API Access
Design Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DSGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();